Transforaminal 5% Phenol Neurolysis for the Treatment of Intractable Cancer Pain
Overview
Affiliations
This is the first case report of using a transforaminal approach for phenol administration. A 76-yr-old patient with a history of leiomyosarcoma and multiple metastatic lesions had unremitting pain in the right thoracic and lumbar regions and had prohibitive opioid-induced side effects. The patient underwent phenol neurolysis using a transforaminal approach in 2 stages at 3 levels (L3-4, L1-2, and T12-L1). The patient had complete resolution of pain, without any complications, and opioid treatment was nearly discontinued. Transforaminal phenol neurolysis is a reasonable treatment option for patients suffering from intractable pain for whom conventional therapies have proven ineffective.
Ahmed A, Thota R, Chatterjee A, Jain P, Ramanjulu R, Bhatnagar S Indian J Palliat Care. 2020; 26(2):203-209.
PMID: 32874034 PMC: 7444568. DOI: 10.4103/0973-1075.285696.
Ahmad U, Abbas S, Hamadani S, Abbas S, Usman S, Hafeez Z Cureus. 2020; 12(4):e7719.
PMID: 32431997 PMC: 7234092. DOI: 10.7759/cureus.7719.
New Cancer Pain Treatment Options.
Candido K, Kusper T, Knezevic N Curr Pain Headache Rep. 2017; 21(2):12.
PMID: 28265859 DOI: 10.1007/s11916-017-0613-0.
The role of chemical neurolysis in cancer pain.
Koyyalagunta D, Burton A Curr Pain Headache Rep. 2010; 14(4):261-7.
PMID: 20524161 DOI: 10.1007/s11916-010-0123-9.